Skip to content
OpenCapital
AI Tools
Earnings
Screener
Charts
Watchlist
Pricing
Connect your AI
Get started
Toggle navigation menu
InfuSystem Holdings
INFU
Concentration Risk %
Concentration Risk % at other companies
Identive
INVE
10.3%
+7.7pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
RF Industries
RFIL
100%
0.0pp
Weis Markets
WMK
100%
0.0pp
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Segments
By product
See full
Third-Party Payer Rentals
37.1%
+5.4%
Services
8.3%
+22.1%
Direct rental services
5.8%
+5.5%
By segment
See full
Patient Services
59.3%
+10.0%
Device Solutions
18.6%
-21.2%
Other financials
Income statement
See full
Revenue
$33.7M
-3.0%
Gross profit
$19.7M
+2.7%
Operating income
$1.6M
+157%
Net income
$1.0M
+481%
EPS (diluted)
$0.05
+600%
Balance sheet
See full
Cash & equivalents
$2.1M
+39.8%
Total debt
$24.1M
-30.4%
Total equity
$58.7M
+6.5%
Total assets
$98.7M
-5.4%
Cash flow
See full
Operating cash flow
$970.0K
-45.5%
CapEx
$157.0K
+19.8%
Free cash flow
$813.0K
-50.7%
Valuation
See full
Market cap
$205.05M
+51.3%
Enterprise value
$227.04M
+36.2%
P/E
25.9×
-0.8×
P/S
1.4×
+0.5×
Profitability
See full
Gross margin
56.7%
+3.6pp
Operating margin
9.1%
+3.0pp
Net margin
5.6%
+3.2pp
FCF margin
16.2%
+1.0pp
Returns & leverage
See full
Return on equity
13.9%
+8.0pp
Debt / equity
0.4×
-0.2×
Current ratio
2.1×
-0.1×